Skip to Main Content

The Markup has found that Facebook is serving up ads and posts for the “abortion pill reversal” procedure, a medically unapproved and potentially dangerous process that the American College of Obstetricians and Gynecologists says is “not based on science.”

Facebook has been circulating this content for years, a practice that both lawmakers and anti-disinformation advocates have publicly criticized. But it’s especially controversial now as interest in medication abortion has spiked with the recent Supreme Court decision overturning Roe v. Wade and resulting physical clinic closures.

advertisement

We found 17 ads from two anti-abortion activist groups circulated on Facebook from October through March. We collected that data through our Citizen Browser project, which gathers posts and group recommendations served to a national panel of Facebook users. Meta’s own ad library showed another group’s abortion reversal ad was live on the platform in May. And regular unpaid Facebook posts pushing the procedure also appeared in our Citizen Browser data as recently as June.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.